ImmunityBio, Inc. — Director's Dealing 2019

Aug 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2019-08-02

Reporting Person: Nelson Sonja (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-02	Common Stock	M	10000	$0.00	Acquired	25000	Direct
2019-08-02	Common Stock	F	3458	$1.27	Disposed	21542	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-02	Restricted Stock Units	$	M	10000	Disposed		Common Stock (10000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of NantKwest, Inc. common stock.

F2: Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 25% of the RSUs will vest on August 2, 2019, and 25% of the RSUs will vest annually thereafter, such that the award will be fully vested on August 2, 2022.